Nonalcoholic Steatohepatitis (NASH) Has Surpassed Hepatitis C as the Leading Etiology for Listing for Liver Transplant: Implications for NASH in Children and Young Adults

被引：0

作者：

Banini, Bubu A. ^{[1
]}

Mota, Manoela ^{[1
]}

Behnke, Martha ^{[2
]}

Sharma, Amit ^{[1
]}

Sanyal, Arun J. ^{[1
]}

机构：

[1] Virginia Commonwealth Univ, Richmond, VA USA

[2] Syst Imaginat Inc, Scottsdale, AZ USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷

关键词：

D O I：

10.14309/00000434-201610001-00755

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

755

引用

页码：S339 / S339

页数：1

共 44 条

[21] PRIMARY CARE (PC) UTILIZATION, PREVENTATIVE SCREENING, AND CONTROL OF METABOLIC SYNDROME (MetS) IN NONALCOHOLIC STEATOHEPATITIS (NASH) LIVER TRANSPLANT (LT) RECIPIENTS
Flynn, Sarah
Brandman, Danielle
HEPATOLOGY, 2020, 72 : 404A - 405A
[22] Characterizing compensated cirrhosis (CC) patients with potential etiology of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH): findings from large Italian administrative databases
Marchesini, G.
Ting, J.
Saragoni, S.
Perrone, V.
Shreay, S.
Petta, S.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E49 - E50
[23] Haptoglobin Genotype 2 Allele Identifies Adults and Children with Nonalcoholic Steatohepatitis (NASH) who Improve Liver Histology and Cardiometabolic risk factors with Vitamin E Treatment
Asgharpour, Amon
Cazanave, Sophie C.
Yates, Katherine P.
Vincent, Robert
Kohli, Rohit
Hameed, Bilal
Cummings, Oscar
Tonascia, James
Sanyal, Arun J.
HEPATOLOGY, 2015, 62 : 290A - 290A
[24] Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection
D'Amico, Fabio
Consolo, Maria
Amoroso, Alfredo
Skarmoutsou, Evangelia
Mauceri, Barbara
Stivala, Franca
Malaponte, Grazia
Bertino, Gaetano
Neri, Sergio
Mazzarino, Maria Clorinda
ACTA HISTOCHEMICA, 2010, 112 (05) : 474 - 481
[25] Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965
Shirazi, Farah
Wang, Jennifer
Wong, Robert J.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (01) : 30 - 36
[26] c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types
Drescher, Hannah K.
Schumacher, Fabienne
Schenker, Teresa
Baues, Maike
Lammers, Twan
Hieronymus, Thomas
Trautwein, Christian
Streetz, Konrad L.
Kroy, Daniela C.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
[27] FURTHER EVIDENCE THAT NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS A THROMBOPHILIC STATE: PLASMINOGEN ACTIVATOR INHIBITOR ONE LEVELS ARE SIGNIFICANTLY ELEVATED IN LIVER TRANSPLANT CANDIDATES WITH DECOMPENSATED NONALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS
Stine, Jonathan
Baragona, Allison
Hummer, Breianna
Rivas, Gloriany
Bezinover, Dmitri
Kadry, Zakiyah
HEPATOLOGY, 2019, 70 : 1346A - 1346A
[28] Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
Golabi, Pegah
Bush, Haley
Stepanova, Maria
Locklear, Cameron T.
Jacobson, Ira M.
Mishra, Alita
Trimble, Gregory
Erario, Madeline
Venkatesan, Chapy
Younossi, Issah
Goodman, Zachary
Younossi, Zobair M.
MEDICINE, 2018, 97 (31)
[29] NASH/Cryptogenic Cirrhosis Patients Are Less Likely Than Hepatitis C Patients To Receive a Liver Transplant.
O'Leary, Jacqueline G.
Jennings, Linda
Davis, Gary L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 257 - 257
[30] Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C
Henson, Jacqueline B.
Wilder, Julius M.
Kappus, Matthew R.
Barbas, Andrew S.
Moylan, Cynthia A.
Niedzwiecki, Donna
Muir, Andrew J.
Berg, Carl L.
Patel, Yuval A.
TRANSPLANTATION, 2020, 104 (06) : E164 - E173

← 1 2 3 4 5 →